CK15-03a

Main Content

Outcome of allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia with antecedent history of philadelphia-negative myeloproliferative neoplasm.

Study #: CK15-03a

Study Status: Published

Presentation(s)

2019, Tandem (Poster)

2020, TCT Meetings (Oral)

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL–negative MPN in blast phase.

Citation

Gupta V, Kennedy JA, Capo-Chichi J-M, Kim S, Hu Z-H, Alyea EP, Popat UR, Sobecks RM, Scott BL, Gerds AT, Salit RB, Deeg HJ, Nakamura R, Saber W.

Blood Advances. 2020, Nov 20: 4(21): 4(21):5562-5573. doi: 10.1182/bloodadvances.2020002727. Epub 2020, Nov 20. PMCID:PMC7656913.

PubMed

PMID: 33170935

Abstract